From: Health system characteristics and COVID-19 performance in high-income countries
 | Model 7a | Model 7b | Model 8a | Model 8b | Model 9a | Model 9b |
---|---|---|---|---|---|---|
 | Β (sd) | Β (sd) | Β (sd) | Β (sd) | Β (sd) | Β (sd) |
(Intercept) | -0.60** | -0.60** | -0.58 | -0.58 | -0.57** | -0.57*** |
 | (0.19) | (0.15) | (0.39) | (0.30) | (0.18) | (0.14) |
Financing type 3 | 1.25*** | 0.94** | Â | Â | Â | Â |
 | (0.34) | (0.27) |  |  |  |  |
Financing type 4 | 1.15** | 0.92** | Â | Â | Â | Â |
 | (0.33) | (0.26) |  |  |  |  |
Provision type 2 | Â | Â | 0.65 | 0.65 | Â | Â |
 |  |  | (0.55) | (0.43) |  |  |
Provision type 4 | Â | Â | 0.17 | 0.17 | Â | Â |
 |  |  | (0.44) | (0.34) |  |  |
Provision type 5 | Â | Â | 1.26* | 0.83* | Â | Â |
 |  |  | (0.47) | (0.37) |  |  |
Combined type 3 | Â | Â | Â | Â | 1.26*** | 0.77** |
 |  |  |  |  | (0.31) | (0.25) |
Combined type 4 | Â | Â | Â | Â | 0.89* | 0.89** |
 |  |  |  |  | (0.34) | (0.26) |
Mexico | Â | 2.82*** | Â | 2.91*** | Â | 2.95*** |
 |  | (0.68) |  | (0.71) |  | (0.64) |
Colombia | Â | 2.26** | Â | 2.33** | Â | 2.37*** |
 |  | (0.67) |  | (0.71) |  | (0.64) |
N | 38 | 38 | 39 | 39 | 39 | 39 |
R2 | 0.35 | 0.65 | 0.28 | 0.59 | 0.34 | 0.66 |
adj. R2 | 0.32 | 0.61 | 0.21 | 0.53 | 0.30 | 0.62 |
logLik | -46.01 | -34.16 | -47.99 | -36.93 | -46.26 | -33.48 |
AIC | 100.02 | 80.32 | 106.00 | 87.85 | 100.52 | 78.96 |
BIC | 106.57 | 90.14 | 114.31 | 99.50 | 107.18 | 88.94 |